Infectious Disease & Vaccines

The acquisition nets Merck a pipeline of oncology programs as well as CD24Fc, OncoImmune's lead candidate for the treatment of COVID-19

A decoy molecule could help to contain outbreaks of Venezuelan equine encephalitis infection

Moderna reports interim efficacy results of 94.5 percent for its COVID-19 vaccine candidate

A look at our new online venue for infectious diseases as well as upcoming coverage

First step is to assess potential therapeutics for COVID-19

Druggable pocket in SARS-CoV-2 spike protein could stop virus

BNT162b2 immunization of rhesus macaques results in strong antiviral effects against SARS-CoV-2

FDA makes a change in its policy of reviewing and granting tests related to the pandemic

The FDA has authorized the first COVID-19 test for self-testing at home

Precision NanoSystems is developing an mRNA vaccine candidate lipid nanoparticle with CanSinoBIO